Mammography Indicator Markers by IZI Medical Products.


April 1, 2010 - Two newly released radiolucent mammography markers are designed to help technologists give radiologists a way to easily identify the area of interest, resulting in a faster and more accurate diagnosis.

The two new lines of flat mammography markers, Mammography Indicator Markers, are available in radiolucent and radiopaque varieties, and function as reference points used by mammography technologists to accurately and reliably indicate an area of interest on the breast (e.g. masses, scar tissue, moles, etc.) in diagnostic mammograms.

Unlike round BBs and wires, which are commonly used in mammography, the flat technology in Mammography Indicator Markers is designed to prevent indentation of the patient’s skin that can create question and confusion in results. The flat technology also eliminates artifacts that often appear on scans due to the use of lesser quality marking technology, therefore eliminating any need for the patient to be rescanned due to artifacts.

The Mammography Indicator Markers include:
• Used in mammography to identify masses, scar tissue, moles, birthmarks, nipples, or any point of interest
• Flat design to prevent indentation of patient tissue to eliminate artifacts
• Available in pink radiolucent ink and radiopaque black ink
• Clear adhesive backing with double pull tabs for application and removal
• Disposable

The manufacturer, IZI Medical Products, uses pink ink allows the markers to appear radiolucent on a scan, and marker will not hide underlying pathology. Other features include:
- Lead free, nontoxic;
- Available in: circles (12 mm); dots (1.5 mm, 2 mm, 2.5 mm); line (2.5 mm, 1.5 mm, 0.8 mm); triangles (10 mm);
Radiopaque - Markers appear radiopaque on a scan - Lead free, nontoxic; and
- Available in: crosses (3.17 mm); dots (3.17 mm); lines (3.3 mm). They are designed to be visible in scans.

For more information: www.izimed.com


Related Content

News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
Feature | Breast Imaging

Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...

Time October 24, 2025
arrow
Subscribe Now